DUBLIN--(BUSINESS WIRE)--The "Protein Engineering Market by Technology (Rational Design, Irrational Design), Product & Service (Instrument, Consumables), Protein Type (Monoclonal Antibodies, Insulin), End User (Academics Institutes, Biopharmaceuticals, CROs) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The increasing focus on protein-based drug development by pharmaceutical and biotechnology firms is expected to drive the overall growth of the protein engineering market
The major factors driving the growth of this market include the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies.
Instruments segment to account for the largest share of the protein engineering market, by product & service, in 2019
Based on product & service, the protein engineering market is segmented into instruments, consumables, and software & services. Instruments formed the largest product segment in this market in 2019 due to technological advancements in mass spectrometry and X-ray crystallography systems and their ability to integrate with other technologies.
Monoclonal antibodies segment to grow at the highest CAGR in the protein engineering market, by protein type, in 2019
Based on protein type, the protein engineering market is segmented into monoclonal antibodies, insulin, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins. The monoclonal antibodies segment is estimated to grow at the highest CAGR in this market owing to the increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.
Rational protein design segment to grow at the highest CAGR in the protein engineering market, by technology, in 2019
Based on technology, the protein engineering market is segmented into rational and irrational protein design. The rational protein design segment is estimated to grow at the highest CAGR in this market during the forecast period majorly due to the growing use and continuous upgrades of bioinformatics platforms and software for protein analysis.
North America is estimated to be the largest regional market for protein engineering products and services during the forecast period
In 2019, North America accounted for the largest share of the global protein engineering market, majorly due to the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research in the region. Also, the increased adoption of biologic drugs such as monoclonal antibodies, erythropoietin, and interferons for the treatment of chronic diseases is the major factor driving the growth of the North American market.
In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the protein engineering market.
Key Benefits of Buying the Report:
This report will help market leaders as well as new entrants in the market by providing information on the closest approximations of the revenue numbers for the overall protein engineering market and its subsegments. It will also help stakeholders to understand the competitive landscape, gain more insights to better position their businesses, and plan suitable go-to-market strategies.
Key Topics Covered:
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Covered
1.4 Years Considered for the Study
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.3 Data Triangulation
2.3.1 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 Asia Pacific: Market, By Product (2018)
4.3 Market, By End User (2018)
4.4 Market, By Region (2018)
5 Market Overview
5.2 Market Dynamics
6 Protein Engineering Market, By Product & Service
6.4 Software & Services
7 Protein Engineering Market, By Protein Type
7.2 Monoclonal Antibodies
7.7 Colony-Stimulating Factors
7.8 Growth Hormones
7.9 Coagulation Factors
7.10 Other Proteins
8 Protein Engineering Market, By Technology
8.2 Rational Protein Design
8.3 Irrational Protein Design/Directed Evolution
9 Protein Engineering Market, By End User
9.2 Biopharmaceutical Companies
9.3 Contract Research Organizations
9.4 Academic Research Institutes
10 Protein Engineering Market, By Region
10.2 North America
10.4 Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.2 Market Rank Analysis, 2018
11.3 Competitive Leadership Mapping (2019)
11.4 Competitive Scenario
12 Company Profiles
12.1 Thermo Fisher Scientific, Inc.
12.2 Danaher Corporation
12.3 Agilent Technologies, Inc.
12.4 Bio-Rad Laboratories, Inc.
12.5 Bruker Corporation
12.6 Genscript Biotech Corporation
12.7 Codexis, Inc.
12.8 Waters Corporation
12.9 New England Biolabs, Inc.
12.10 Merck KGaA
12.11 Perkinelmer, Inc.
12.12 GE Healthcare
12.13 Creative Biolabs
12.14 Enantis S.R.O.
12.15 Promega Corporation
12.16 Abzena, Ltd.
12.18 Innovagen AB
12.19 Phynexus, Inc. (A Part of Biotage)
12.20 Takara Bio, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/lenqlk